MeSH term
Frequency | Condition_Probility | Adult | 16 | 0.0 |
Base Sequence | 13 | 0.0 |
DNA, Complementary/chemistry/genetics | 2 | 0.0 |
Female | 17 | 0.0 |
Humans | 42 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Keratin/analysis | 2 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Oncogene Proteins, Fusion/*genetics | 8 | 4.0 |
RNA, Neoplasm/genetics | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Gene Library | 5 | 0.0 |
Hela Cells | 3 | 0.0 |
Male | 22 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Chromosomes, Human, Pair 18 | 5 | 4.0 |
Sarcoma, Synovial/chemistry/*genetics | 2 | 66.0 |
X Chromosome | 6 | 1.0 |
*Membrane Proteins | 7 | 0.0 |
Neoplasm Proteins/*analysis | 2 | 0.0 |
Animals | 4 | 0.0 |
Cell Division | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Translocation, Genetic | 5 | 0.0 |
Adolescent | 9 | 0.0 |
Aged | 11 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Child | 6 | 0.0 |
Karyotyping | 4 | 0.0 |
Middle Aged | 10 | 0.0 |
Neoplasm Proteins/genetics | 4 | 0.0 |
Oncogene Proteins, Fusion/genetics | 3 | 3.0 |
Proteins/genetics | 3 | 0.0 |
Repressor Proteins/genetics | 5 | 3.0 |
Gene Expression | 2 | 0.0 |
Testis/*immunology | 2 | 50.0 |
Proteins/*genetics | 4 | 0.0 |
Sarcoma, Synovial/*genetics/pathology | 3 | 75.0 |
Sequence Alignment | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 5 | 0.0 |
Tissue Distribution | 3 | 0.0 |
*Chromosomes, Human, Pair 18 | 5 | 3.0 |
Neoplasm Proteins/*genetics | 4 | 0.0 |
Repressor Proteins/*genetics | 7 | 2.0 |
Translocation, Genetic/*genetics | 2 | 0.0 |
*X Chromosome | 5 | 0.0 |
Translocation, Genetic/genetics | 2 | 2.0 |
Prognosis | 3 | 0.0 |
Survival Analysis | 2 | 0.0 |
Antibody Specificity | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Transfection | 3 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Antigens, Neoplasm/*genetics | 2 | 3.0 |
Disease-Free Survival | 2 | 0.0 |
Sarcoma, Synovial/*genetics | 6 | 40.0 |
Antibodies, Neoplasm/*blood | 2 | 22.0 |
Melanoma/immunology | 2 | 5.0 |
Neoplasms/*immunology | 2 | 1.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
Gene Fusion | 2 | 2.0 |
*Translocation, Genetic | 8 | 0.0 |
Paraffin Embedding | 2 | 0.0 |
Sarcoma, Synovial/*genetics/mortality/pathology | 2 | 100.0 |
Survival Rate | 2 | 0.0 |
Tumor Markers, Biological/genetics | 2 | 2.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
Proteins/genetics/immunology | 2 | 18.0 |
*Neoplasm Proteins | 5 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |